[{"id":"4153df62-5564-41bf-9a5c-30bd7c1709a9","acronym":"","url":"https://clinicaltrials.gov/study/NCT06115642","created_at":"2023-11-03T21:12:39.056Z","updated_at":"2025-02-25T16:19:15.217Z","phase":"Phase 1","brief_title":"A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT06115642","lead_sponsor":"Shanghai Henlius Biotech","biomarkers":" DDX5","pipe":" | ","alterations":" PD-L1 expression","tags":["DDX5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLX43"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 11/28/2023","start_date":" 11/28/2023","primary_txt":" Primary completion: 06/30/2025","primary_completion_date":" 06/30/2025","study_txt":" Completion: 11/30/2025","study_completion_date":" 11/30/2025","last_update_posted":"2024-01-10"}]